Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver Transplantation
Open Access
- 1 January 2005
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 5 (1), 118-124
- https://doi.org/10.1111/j.1600-6143.2004.00648.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment1,2,3Gastroenterology, 2004
- Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantationLiver Transplantation, 2003
- A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis CHepatology, 2002
- Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacyLiver Transplantation, 2002
- Treatment of ribavirin/interferon-induced anemia with erythropoietin in patients with hepatitis CHepatology, 2002
- Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot studyNephrology Dialysis Transplantation, 2001
- Pharmacokinetics of Natural Human IFN-α in Hemodialysis PatientsJournal of Interferon & Cytokine Research, 1999
- The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantationHepatology, 1998
- INTERFERON-?? FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATITIS C IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1998
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationThe New England Journal of Medicine, 1996